GeneBio Systems
Phospho-GSK3 beta (Ser9) Polyclonal Antibody
Phospho-GSK3 beta (Ser9) Polyclonal Antibody
SKU:E-AB-20886
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Acetyl/Phospho/Methyl Antibodies
Abbreviation: GSK3β (phospho Ser9)
Target Synonym: Glycogen Synthase Kinase 3 Beta;Glycogen synthase kinase-3 beta;GSK 3 beta;GSK-3 beta;GSK3B;GSK3B;GSK3beta isoform;Serine/threonine-protein kinase GSK3B
Research Areas: Cancer;Cardiovascular;Metabolism;Neuroscience;Signal Transduction;Stem Cells
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human;Mouse;Rat
Application: WB;IHC-p;IF
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: P49841
Accession:
Background: Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin. Phosphorylates SNAI1. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Phosphorylates MACF1 and this phosphorylation inhibits the binding of MACF1 to microtubules which is critical for its role in bulge stem cell migration and skin wound repair.
Concentration: 1 mg/mL
Immunogen: Synthesized peptide derived from human GSK3β around the phosphorylation site of Ser9
Buffer: PBS with 0.02% sodium azide, 0.5% protective protein and 50% glycerol, pH7.4
Purification method: Affinity purification
Dilution: WB 1:500-1:2000;IHC 1:100-1:300;IF 1:100-1:300
Calculated MW: 47kDa
ObservedMW: 48kDa
